Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and resistant hypertension.

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of ...

Santo Domingo- The Central Bank reported on Thursday that February’s inflation closed with a slight growth of 0.32%, driven ...

Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at ...

Lorundrostat is an orally-administered highly selective aldosterone synthase inhibitor that reduces aldosterone levels by inhibiting CYP11B2. The Launch-HTN trial (ClinicalTrials.gov Identifier: ...

Senate panel rules Senator Natasha's petition dead on arrival FEC signs ₦10 billion for diabetes and HIV/AIDS treatment National grid generated highest ...

Other drugs include various antibiotics like amikacin and streptomycin which are used for treating infections, diuretics like furosemide used in cardiac failure, antihypertensives (when causing ...

Act quickly with uterine massage, oxytocics, tranexamic acid, IV fluids, and genital tract examination and prepare for blood transfusion if needed, among others. Thank you for reading Nation.Africa ...

The federal government has approved contracts worth ₦10.3 billion to enhance access to essential healthcare services and medical commodities in Nigeria.